TITLE

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation

PUB. DATE
January 2007
SOURCE
BMC Public Health;2007, Vol. 7 Issue 1, p130
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43830437

 

Related Articles

  • Worldwide tracking of Neisseria meningitidis. Taha, Muhamed-Kheir // Journal of Postgraduate Medicine;Jan-Mar2006, Vol. 52 Issue 1, p29 

    The article reports on the improved understanding of meningococcal epidemiology through the use of improved techniques for isolate characterization. Serological typing methods are used to determine the antigenic formulas of isolates. Molecular characterization is based on the analysis of the...

  • Control of Invasive Meningococcal Disease. Sadovsky, Richard // American Family Physician;12/1/1999, Vol. 60 Issue 9, p2670 

    Presents an abstract of the study `The Epidemiology and Control of Invasive Meningococcal Disease,' by P.S. Diaz which appeared in the July 1999 issue of `Pediatrics Infectious Disease Journal.'

  • 'Tis the season: meningococcal disease. Murray, Sally // CMAJ: Canadian Medical Association Journal;12/6/2005, Vol. 173 Issue 12, p1443 

    Offers information about invasive meningococcal disease. Epidemiology; Clinical management; Diagnosis; Contact management; Vaccination.

  • American Academy of Pediatrics addresses meningococcal disease prevention and control strategies.  // American Family Physician;7/1/1996, Vol. 54 Issue 1, p362 

    Presents the position of the American Academy of Pediatrics regarding the prevention and control of meningococcal disease. Epidemiology of meningococcal disease; Risk assessment of contacts; Use of meningococcal vaccine; Use of microbiology laboratory.

  • School-based clusters of meningococcal disease in the United States. Zangwill, Kenneth M.; Schuchat, Anne // JAMA: Journal of the American Medical Association;2/5/97, Vol. 277 Issue 5, p389 

    Presents a study in which researchers evaluated the epidemiologic features and risk factors for multiple cases of meningococcal disease in schools in the United States. Study design; Setting; Main outcome measures; Results, including the identification of 22 clusters of meningococcal disease;...

  • Meningococcal disease: A brief primer. Foster, Stephan L.; Turner, Brittney P.; McManus, Jessicca; Meadows, Jeffrey R.; Shelton, Chasity M. // Journal of the American Pharmacists Association: JAPhA;May/Jun2015, Vol. 55 Issue 3, p331 

    The article discusses meningococcal disease, a bacterial illness that is transmitted via direct exchange of respiratory droplets and throat secretions of an individual infected with Neisseria meningitidis. Particular fous is given to the clinical manifestations of invasive meningococcal disease...

  • Dexamethasone as adjuvant therapy in the treatment of invasive meningococcal diseases. Tolaj, Ilir; Dreshaj, Shemsedin; Qehaja, Emine; Tolaj, Jasmina; Doda-Ejupi, Teuta; Mehmeti, Murat // Medicinski Arhiv;2010, Vol. 64 Issue 4, p228 

    Purpose: With this study we want to evaluate the role of dexamethasone adjuvant treatment in different clinical forms of invasive meningococcal diseases. Work Methods: This was a randomized, open label trial that was conducted in 147 individuals with meningococcal sepsis. All of the cases have...

  • Technical consultation meeting on WHO strategy for the Prevention and Control of epidemic meningococcal disease in Africa, Ouagadougou, 23-24 September 2002.  // Weekly Epidemiological Record;9/13/2002, Vol. 77 Issue 37, p316 

    Focuses on the technical consultation meeting of the World Health Organization strategy for the prevention and control of epidemic meningococcal disease in Africa. Changes in the epidemiology of meningococcal meningitis; Threat posed by the emergence of Neisseria meningitidis.

  • Conjugated vaccines against serogroup A, C, W-135 and y disease. Sáfadi, Marco Aurelio P. // Revista VacciMonitor (Vacunología y Temas Afines);May-Aug2009, Vol. 18 Issue 2, p59 

    Review the current evidence on available and candidate quadrivalent meningococcal conjugate vaccines. Methods: A comprehensive overview of data on the currently available A-C-W135-Y meningococcal vaccine and the results of late stage development of novel quadrivalent candidate vaccines were...

  • Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease. Cohn, Amanda C.; MacNeil, Jessica R.; Harrison, Lee H.; Hatcher, Cynthia; Theodore, Jordan; Schmidt, Mark; Pondo, Tracy; Arnold, Kathryn E.; Baumbach, Joan; Bennett, Nancy; Craig, Allen S.; Farley, Monica; Gershman, Ken; Petit, Susan; Lynfield, Ruth; Reingold, Arthur; Schaffner, William; Shutt, Kathleen A.; Zell, Elizabeth R.; Mayer, Leonard W. // Clinical Infectious Diseases;1/15/2010, Vol. 50 Issue 2, p184 

    Background. In January 2005, a quadrivalent (serogroups A, C , Y, and W-135) meningococcal conjugate vaccine was licensed for use in adolescents. This report describes the epidemiologic features of meningococcal disease in the United States from January 1998 through December 2007, before and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics